+ Watch ZIXI
on My Watchlist
The Company provides easy-to-use-and-deploy e-communication services that connect enterprises and consumers in the healthcare, finance, insurance, and government sectors to protect and deliver sensitive information.
Revenue growth is nearly gone. 3Q is announced to be 1% over 2nd quarter, which was 1% over the 1st quarter of this year.Zix has not diversified. They put their cash into a stock buyback at $3.5 which only served to cover up the massive dilution due to overpaid management getting fat stock options.Zix's founder, David Cook quit the board 6 months ago and sold all of his stock.No insider has bought stock in 2 years.Dead meat.
Fabulous analysis!Says it all, except for the patent suit.
The recent activity in the patent office regarding the reexam will kill zix.Their only hope was that the stock was invalid.The court in California already rule that the Rpost patent asserted against zix was valid. Now that the reexam is reaching the same conclusion, all hope is gone.
Zix patent suit is getting really serious. The patent office looks like it will recertify the Rpost patent within a few weeks. Rpost will go to trial against another firm, Trustifi in June. If they win then, look to zixi to completely tank.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions